期刊文献+

趋化因子CXCL13对TNF-α诱导的人骨关节滑膜细胞RANKL表达的影响 被引量:1

Influence of CXCL13 on expression of RANKL in human synovial cells induced by TNF-α
下载PDF
导出
摘要 目的探讨趋化因子CXCL13对TNF-α诱导的人骨关节滑膜细胞调控细胞核因子-κB受体活化因子配体(RANKL)表达的影响。方法 (1)体外培养人骨关节滑膜细胞,并给予10μg/m L TNF-α处理,分别在培养0、6、12、24 h时采用免疫荧光法检测CXCL13表达。(2)人滑膜细胞给予10μg/m L TNF-α处理24 h,将培养液更换为含0、5、10、25 ng/m L CXCL13的培养液继续培养24 h,或将培养液更换为含25 ng/m L CXCL13的培养液分别作用0、1、3、6、24 h;以不加TNF-α及CXCL13处理的常规培养细胞作为对照细胞。收集各浓度、各时间点细胞,采用Western blotting法检测RANKL蛋白相对表达量。结果 (1)TNF-α作用0、6、12、24 h时细胞CXCL13相对表达量(荧光强度)分别为0.907±0.350、0.823±0.730、0.710±0.660、0.653±0.850,组间比较P均<0.05。(2)对照细胞RANKL蛋白相对表达量为0.956±0.014,25 ng/m L CXCL13处理0、1、3、6、24 h时RANKL蛋白相对表达量分别为1.543±0.047、1.366±0.026、0.883±0.026、0.367±0.034、0.246±0.015;0、5、10、25 ng/m L CXCL13作用24 h时RANKL蛋白相对表达量分别为0.287±0.007、0.189±0.008、0.069±0.004、0.022±0.002;上述各组、各时间及各浓度细胞比较P均<0.05。结论趋化因子CXCL13能够在一定浓度和时间内抑制TNF-α诱导的人骨关节滑膜细胞RANKL蛋白表达。 Objective To investigate the effect of CXCL13 on the expression of receptor activator of NF-κB ligand( RANKL) in human synovial cells induced by tumor necrosis factor-α( TNF-α). Methods(1) The human synovial cells were cultured in vitro and were treated with 10 g/mL TNF-α. At 0,6,12,and 24 h,we used immunofluorescence to detect the CXCL13 expression.(2) The human synovial cells cultured in vitro were treated with 10 g/mL TNF-α for 24 h,after that,we replaced the culture fluid with medium containing 0,5,10,and 25 ng/mL CXCL13 and continued to culture for 24 h,or replaced the culture fluid with medium containing 25 ng/mL CXCL13 and continued to culture for 0,1,3,6,and 24 h. The relative expression of RANKL was detected by Western blotting. The normal cultured cells without treatment of TNF-α and CXCL13 were used as the control group. Results(1)The expression levels of CXCL13( fluorescence intensity) were 0. 907 ± 351,0. 823 ± 735,0. 710 ± 664,and 0. 653 ± 853 in cells treated with TNF-α at 0,6,12,and 24 h( all P〈0. 05).(2)The expression of RANKL protein was 0. 956 ± 0. 014 in the control group,and the expression levels of RANKL protein in cells treated with 25 ng/mL CXCL13 for 0,1,3,6,and 24 h were 1. 543 ± 0. 047,1. 366 ± 0. 026,0. 883 ± 0. 026,0. 367 ± 0. 034,and 0. 246 ± 0. 015; the expression levels of RANKL protein in cells treated with different contentrations( 0,5,10,25 ng/mL) of CXCL13 were 0. 287 ± 0. 007,0. 189 ± 0. 008,0. 069 ± 0. 004,and 0. 022 ±0. 002; significant difference was found between them( all P〈0. 05). Conclusion CXCL13 can inhibit the expression of RANKL protein of osteoarticular synovial cells induced by TNF-α in a certain concentration and time.
出处 《山东医药》 CAS 北大核心 2017年第48期5-8,共4页 Shandong Medical Journal
基金 吉林省教育厅科学技术研究"十二五"规划课题资助项目(吉教科合字201310)
关键词 骨关节炎 趋化因子CXCL13 肿瘤坏死因子Α 细胞核因子-κB受体活化因子配体 人骨关节滑膜细胞 osteoarthritis chemokine CXCL13 tumor necrosis factor-α receptor activator of NF-κB ligand (RANKL) human synovial cells
  • 相关文献

参考文献1

二级参考文献21

  • 1Blagojevic M, ]inks C, ]effery A, et al. Risk factors for onset of osteoarthritis of the knee in older adults: a systematic review and meta-analysis. Osteoarthritis Cartilage, 2010, 18(1): 24-33.
  • 2Gerard C, Rollins BJ. Chemokines and disease. Nat Immunol, 2001, 2(2): 108-115.
  • 3Bugatti S, Manzo A, Vitolo B, et al. High expression levels Of the B cell chemoattractant CXCL13 in rheumatoid synovium are a marker of severe disease. Rheumatology (Oxford), 2014, 53(10): 1886-1895.
  • 4Greisen S, Schelde K, Rasmussen T, et al. CXCL13 predicts disease activity in early rheumatoid arthritis and ~ould be an indicator of the therapeutic window of opportunity. Arthritis Res Ther, 2014, 16(5): 434.
  • 5Jones ID, Hamilton B], Challener G], et al. Serum C-X-C motif chemokine 13 is elevated in early and established rheumatoid arthritis and correlates with rheumatoid factor levels. Arthritis Res Ther, 2014, 16(2): R103.
  • 6Platas J, Guill6n MI, Del Caz MD, et al. Conditioned media from adipose-tissue~derived mesenchymal stem cells downregulate degradative mediators induced by interleukin-l~ in osteoarthritic chondrocytes. Mediators Inflarnrn, 2013 : 354014.
  • 7Liu C, Weng YG, Yuan TX, et al. CXCL12/CXCR4 signal axis plays an important role in mediating bone morphogenetic protein 9-induced osteogenic differentiation of mesenchymal stem cells. Int ] Med Sci, 2013, 10(9): 1181-1192.
  • 8Forestier R, Francon A, Briole V, et al. Prevalence of generalized osteoarthritis in a population with knee osteoarthritis. Joint Bone Spine, 2011, 78(3): 275-278.
  • 9Yamairi F, Utsumi H, Ono Y, et al. Expression of vascular endothelial growth factor (VEGF) associated with histopathological changes in rodent models of osteoarthritis. ] Toxicol Pathol, 2011, 24(2): 137-142.
  • 10Sartori-Cintra AR, Mara CS, Argolo DL, et al. Regulation of hypoxia-inducible factor-la(HIF-lct)expression by interleukin- I~(IL-I~), insulin-like growth factors I (IGF-I) and II (IGF-II) in human osteoarthritic chondrocytes. Clinics (Sao Paulo), 2012, 67(1): 35-40.

共引文献3

同被引文献12

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部